Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Microbiota × Cyclophosphamide × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 69 Lymphoma, Large B-Cell, Diffuse 36 Multiple Myeloma 35 Lymphoma 33 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Leukemia 25 Lymphoma, Non-Hodgkin 23 Burkitt Lymphoma 17 Recurrence 16 Lymphoma, Follicular 16 Leukemia, Lymphocytic, Chronic, B-Cell 16 Neoplasms, Plasma Cell 15 Lymphoma, Mantle-Cell 15 Lymphoma, B-Cell 14 Leukemia, Myeloid, Acute 12 Hodgkin Disease 12 Neuroblastoma 11 Lymphoma, Large-Cell, Immunoblastic 10 Lymphoma, T-Cell, Peripheral 9 Lymphoma, B-Cell, Marginal Zone 9 Sarcoma 8 Ovarian Neoplasms 8 Triple Negative Breast Neoplasms 7 Myelodysplastic Syndromes 7 Inflammatory Breast Neoplasms 7 Melanoma 6 Immunoblastic Lymphadenopathy 6 Hematologic Neoplasms 6 Neoplasms 5 Neoplasm Metastasis 5

Interventions

Tablets 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04138979 2019-10-25

Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

First Affiliated Hospital of Harbin Medical University

Microbiota

Data powered by HemOnc (CC BY 4.0) Colophon ⚡